Yuan Zhi
Stock Analyst at B. Riley Securities
(0.26)
# 4,097
Out of 4,761 analysts
19
Total ratings
16.67%
Success rate
-29.67%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintains: Buy | $16 → $8 | $2.36 | +238.98% | 2 | Nov 11, 2024 | |
| MIR Mirion Technologies | Initiates: Buy | $14 | $15.82 | -11.50% | 1 | Sep 26, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $3.32 | +442.17% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $6.22 | +141.16% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $1.15 | +160.87% | 1 | May 15, 2024 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $17 | $2.78 | +511.51% | 2 | Apr 9, 2024 | |
| AZTA Azenta | Maintains: Buy | $61 → $79 | $44.75 | +76.54% | 3 | Feb 1, 2024 | |
| ATNM Actinium Pharmaceuticals | Maintains: Buy | $20 → $16 | $1.17 | +1,267.52% | 4 | Dec 11, 2023 |
Tango Therapeutics
Nov 11, 2024
Maintains: Buy
Price Target: $16 → $8
Current: $2.36
Upside: +238.98%
Mirion Technologies
Sep 26, 2024
Initiates: Buy
Price Target: $14
Current: $15.82
Upside: -11.50%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $3.32
Upside: +442.17%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $6.22
Upside: +141.16%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $1.15
Upside: +160.87%
Perspective Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $2.78
Upside: +511.51%
Azenta
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $44.75
Upside: +76.54%
Actinium Pharmaceuticals
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.17
Upside: +1,267.52%